The fundamentally different disciplines of microelectronics and molecular biology today both operate on the same length scales of micrometers and nanometers. Increasingly, they also make use of the same tools. The expanding overlap between the two fields – the discipline of bioelectronics – will give rise to entirely new approaches to biotechnology and information technology [MBKonvergenz]. Systems such as pacemakers, cochlear implants, brain stimulators for Parkinson patients, etc. are already being used as electronic prostheses in the human body. And wearables used as wristbands are evolving into devices for monitoring health data as part of a medical Internet-of-Things (IoT).
High standards of data security and data protection should exist, especially for health data. Unfortunately, however, the critical situation is emerging for a large area of digital technology, where privacy is rarely guaranteed on the Internet. In many cases, users’ data is collected on a large scale in order to derive personality profiles and control our consumer behavior. The foundations must be laid today to ensure that the great opportunities offered by bioelectronics are used in a responsible manner tomorrow [II.3].
Due to the increasing importance of the field, the Joint Lab Bioelectronics was founded by TU Berlin and IHP. The aim of the lab is to exploit the advantages of microelectronics in biotechnology through common projects and investigations. In addition, students from the life sciences are to learn at an early stage how to use the microelectronic toolbox, for which various courses are held (cf. Teaching). Current developments at the JLB can be followed on Mastodon: mastodon.social/@JLBe.
Essential dynamics for the convergence of microelectronics and biotechnology derives from the field of biomolecular sensing and is due to the large cost pressure in the health sector. Here, the efficient techniques enabled by microelectronics may contribute to the analytics of various human metabolites, which are of importance for the patient’s health and have to be monitored regularly.
One of the critically important metabolites in the human body is glucose, which delivers the chemical energy required for practically all aspects of living. Its transport into the cells is carried out via an insulin-controlled transporter protein. In case of a deficient insulin level, as it occurs in diabetic patients, the increased glucose level in the blood may cause serious secondary health effects. It would be very desirable to dispose of a continuous glucose monitor acting as an implant in the patient in order to avoid or reduce hypo- and hyperglycamic states.
At IHP in Frankfurt/Oder we are developing a minimally invasive glucose sensor, by which diabetics may continuously control the glucose concentration . The sensor operates by the principle of affinity viscosimetry and relies on the competing binding reaction between a plant protein (concanavalin A) and a saccharide, i.e. glucose or dextran. For this purpose, a sensoric liquid containing ConA and dextran is filled into a cavity and interacts via a semi-permeable membrane with the interstitial tissue. The variation of glucose concentration in the latter causes a variation of the sensoric fluid’s viscosity, which is detected by a flexible cantilever within the cavity; a schematics of the sensor principle is shown in the figure. By virtue of modern microelectronic [56, 58] and microsystem technology  the sensor unit may be miniaturized to a volume of only a few cubic millimeters and may thus be applied to a human body over durations of a few days.
Hybrid materials from both worlds – the biomolecular and the semiconductor one – will become an important branch in future material science. Their today applications are mainly in the area of biomolecular sensing. In a first approach MEMS devices will be developed that combine biochemical assay techniques with the miniaturizing potential of silicon manufacturing. Various sensor principles may be used for such systems like the gravimetric detection via surface acoustic waves. In a second step, the convergence of biomolecules and semiconductors in fully CMOS-integrated devices will allow for the realization of sensors and bioelectronic circuits with completely new functionalities.
Regarding the fundamental physics of future bioelectronic devices it is evident that the interface between biomolecules and semiconductors represents the main challenge for a convergence of both material worlds. Open questions are related to the transmission of information via the interface or the local control of biomolecular bonding. From the viewpoint of structural research the perspective is of interest, how the nanotemplating of semiconductor surfaces may enable a local control of biomolecular bonding. Such a technique would open the path for biophysical and other studies of molecular interaction between active biological species like proteins and their ligands. These questions are currently in the focus of modern life sciences after the sequenzing of the human and other genomes has deciphered the control centers of eucariot cells and it has to be elucidated, how the mechanics of the cell is operative in detail. Fascinating perspectives can be realized for this research field with modern CMOS semiconductor technology at hand .
First investigations have begun by using the currently performed transition of IHP technology down to the 130 nm lithography node. To give an example, the figure to the right displays an AFM-measured sub-nanometer topography that may be inscribed into standard Si wafers  and that may serve as a nanotemplate for subsequent immobilization protocols.